How are countries in sub-Saharan African monitoring the impact of programmes to prevent vertical transmission of HIV?

dc.contributor.authorGoga, Ameena Ebrahim
dc.contributor.authorSingh, Yagespari
dc.contributor.authorJackson, Debra
dc.contributor.authorMukungunugwa, Solomon
dc.contributor.authorWafula, Rose
dc.contributor.authorEliya, Michael
dc.contributor.authorNg’ambi, Wingston Felix
dc.contributor.authorNabitaka, Linda
dc.contributor.authorChirinda, Witness
dc.contributor.authorBhardwaj, Sanjana
dc.contributor.authorEssajee, Shaffiq
dc.contributor.authorHayashi, Chika
dc.contributor.authorPillay, Yogan
dc.date.accessioned2020-07-16T14:26:50Z
dc.date.available2020-07-16T14:26:50Z
dc.date.issued2019
dc.description.abstractVertical transmission of HIV can occur during pregnancy, delivery, or through breast feeding. The main driver of vertical transmission is a high maternal viral load. Between 2002 and 2016, low and middle income countries (LMICs) in sub-Saharan Africa with high HIV prevalence improved their policies to prevent vertical transmission of HIV. In 2002, national policies recommended single dose nevirapine at the onset of labour, with limited or no breast feeding. By 2016, all Global Plan priority countries in sub-Saharan Africa (where 90% of the world’s HIV positive pregnant women live) had adopted Option B+ with promotion of breast feeding. Option B+ was a dramatic policy change recommending lifelong triple antiretroviral therapy (ART) for all pregnant and lactating women living with HIV. The aim is to protect the child from HIV infection, ensure the mother’s future health, and prevent horizontal transmission of HIV.en_ZA
dc.description.departmentPaediatrics and Child Healthen_ZA
dc.description.librarianam2020en_ZA
dc.description.sponsorshipThe South African Medical Research Council (SAMRC)en_ZA
dc.description.urihttp://www.bmj.com/thebmjen_ZA
dc.identifier.citationGoga, A., Singh, Y., Jackson, D. et al. How are countries in sub-Saharan African monitoring the impact of programmes to prevent vertical transmission of HIV? BMJ 2019;364:l660 http://dx.DOI.org/10.1136/bmj.l660.en_ZA
dc.identifier.issn0959-8138 (print)
dc.identifier.issn1756-1833 (online)
dc.identifier.other10.1136/bmj.l660
dc.identifier.urihttp://hdl.handle.net/2263/75325
dc.language.isoenen_ZA
dc.publisherBMJ Publishing Groupen_ZA
dc.rights© The Author(s). 2019. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 Internationa License.en_ZA
dc.subjectTransmissionen_ZA
dc.subjectInfectionen_ZA
dc.subjectPregnancyen_ZA
dc.subjectHuman immunodeficiency virus (HIV)en_ZA
dc.subjectVertical transmissionen_ZA
dc.subjectLow- and middle-income countries (LMICs)en_ZA
dc.subjectSub-Saharan Africa (SSA)en_ZA
dc.subjectAntiretroviral therapy (ART)en_ZA
dc.titleHow are countries in sub-Saharan African monitoring the impact of programmes to prevent vertical transmission of HIV?en_ZA
dc.typeArticleen_ZA

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Goga_How_2019.pdf
Size:
184.17 KB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: